PD‐L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer

OBJECTIVE: Neuroendocrine cervical cancer (NECC) is a rare cervical cancer with high aggressivity that causes poor prognosis even in the early stage. Given other neuroendocrine carcinomas and other types of cervical cancer have been proved to have expression of programmed cell death protein 1 ligand...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xiaoyu, Sui, Lei, Song, Kejuan, Lv, Teng, Zhao, Han, Yao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290238/
https://www.ncbi.nlm.nih.gov/pubmed/34076351
http://dx.doi.org/10.1002/cam4.4034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290238/
https://www.ncbi.nlm.nih.gov/pubmed/34076351
http://dx.doi.org/10.1002/cam4.4034

Ejemplares similares